Insulet | Frais De Vente Et D'Administration





Frais De Vente Et D'Administration Changement Date
Abbott USD 3.13B 125M 2025-12
Align Technology USD 441.68M 23.88M 2025-12
AtriCure USD 78.34M 109K 2025-12
Avanos Medical USD 77.6M 5.9M 2025-09
Baxter International USD 761M 53M 2025-12
Becton, Dickinson and Co. USD 1.39B 27M 2025-12
Boston Scientific USD 1.83B 93M 2025-12
Cardinal Health USD 1.5B 43M 2025-12
Cooper Companies USD 419.2M 12M 2025-09
Dexcom USD 299.9M 31.5M 2025-12
Edwards Lifesciences USD 602.9M 88.3M 2025-12
Eli Lilly USD 3.13B 391.3M 2025-12
Globus Medical USD 313.6M 9.98M 2025-09
ICU Medical USD 155.81M 3.04M 2025-12
Inogen USD 43.77M 510K 2024-06
Insulet USD 331.4M 16.2M 2025-12
Integra LifeSciences USD 169.05M 10.84M 2025-09
J&J USD 6.75B 831M 2025-12
Masimo USD 116.4M 20.5M 2025-09
Medtronic 2.97B 159M 2025-09
Merit Medical Systems USD 107.38M 5.72M 2025-09
Roche Holding CHF 7.28B 3.99B 2025-12
Solventum Corp USD 744M 28M 2025-09
Stryker USD 2.14B 150M 2025-12
Tandem Diabetes Care USD 99.86M 5.34M 2025-12
Teleflex USD 281.76M 66.68M 2025-09
West Pharmaceutical Services USD 106.5M 3.8M 2025-12
Zimmer Biomet Holdings USD 855.7M 44.3M 2025-12


Insulet Frais De Vente Et D'Administration - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.